Norton Rose has landed a role on Nestle’s $2.5bn (£1.3bn) acquisition of the nutrition arm of pharmaceuticals giant Novartis.

The instruction is the firm’s biggest-ever for the client and comes after it was appointed to Nestle’s panel for European M&A in 2003.